Comparative Effectiveness of Darunavir 1,200 Mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients

AIDS Research and Treatment - United States
doi 10.1155/2013/687176
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Boosted Tipranavir Versus Darunavir in Treatment-Experienced Patients

Drugs in R and D
Pharmacology
2011English

Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Daily Dosing for Bedaquiline in Patients With Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged≥3 to <12 Years

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2015English

Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients

Current HIV Research
VirologyInfectious Diseases
2009English

Comparative Effectiveness of Revascularization Strategies

New England Journal of Medicine
Medicine
2012English

Comparative Effectiveness of Screening Strategies for Colorectal Cancer

Cancer
Cancer ResearchOncology
2017English

Appropriate Clinical Use of Darunavir 800 Mg

Southern African Journal of HIV Medicine
Infectious Diseases
2018English

Pin61 - Cost-Effectiveness of Once-Daily Darunavir Containing Single-Tablet Regimen (D/C/F/Taf) Compared With Other Multi-Tablet Regimens Containing Boosted Protease Inhibitors (Bpis)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy